A director at Crescent NV sold 135,000,000 shares at 0.007EUR and the significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...
Looking at Wolters Kluwer's[de] equity price, the company seems somewhat out of favour with investors. Nevertheless, we like Wolters Kluwer's strong cash generation and credit profile and deem recent M&A transactions favourable. The spread on the notes of Wolters Kluwer looks attractive, in our view.
Share Buyback Transaction Details August 14 – August 20, 2025 PRESS RELEASE Share Buyback Transaction Details August 14 – August 20, 2025 Alphen aan den Rijn – August 21, 2025 - Wolters Kluwer (Euronext: WKL), a global leader in professional information solutions, software and services, today reports that it has repurchased 89,500 of its own ordinary shares in the period from August 14, 2025, up to and including August 20, 2025, for €10.1 million and at an average share price of €112.94. These repurchases are part of the share buyback program annou...
A director at Wolters Kluwers maiden bought 1,875 shares at 131.520USD and the significance rating of the trade was 81/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
Share Buyback Transaction Details August 7 – August 13, 2025 PRESS RELEASE Share Buyback Transaction Details August 7 – August 13, 2025 Alphen aan den Rijn – August 14, 2025 - Wolters Kluwer (Euronext: WKL), a global leader in professional information solutions, software and services, today reports that it has repurchased 137,900 of its own ordinary shares in the period from August 7, 2025, up to and including August 13, 2025, for €16.2 million and at an average share price of €117.75. These repurchases are part of the share buyback program announc...
Ascencio: Stable update CFE: Preview; margin over volume CVC Capital Partners: Moments of Realisation D'Ieteren: Belron North American peer Boyd points to positive 3Q25 inflection point in like for like growth Fastned: 1H25 results; disappointing charging volumes, cost pressure continues Greenyard: Results of second acceptance period concerning takeover bid and launching squeeze-out
Share Buyback Transaction Details July 31 – August 6, 2025 PRESS RELEASE Share Buyback Transaction Details July 31 – August 6, 2025 Alphen aan den Rijn – August 7, 2025 - Wolters Kluwer (Euronext: WKL), a global leader in professional information solutions, software and services, today reports that it has repurchased 109,700 of its own ordinary shares in the period from July 31, 2025, up to and including August 6, 2025, for €14.5 million and at an average share price of €132.48. These repurchases are part of the share buyback program announced on...
1M Performance - Absolute Total Return: During Jul'25 (1M period), the KBCS Holdings Universe posted a total return of -0.5% which was mainly driven by the performance of the multi-asset holdings (-0.9%), while the single-asset holdings posted a return of +0.4%. The 3 top performers during the period were Financière de Tubize (+11.7%), KBC Ancora (+9.4%) and Quest For Growth (+5.5%) while the 3 worst performers were Brederode (-6.4%), Heineken Holding (-5.0%) and D'Ieteren Group (-4.7%). YTD Pe...
Wolters Kluwer reported a solid 1H25 update. We make small adjustments to our organic growth and margin forecasts, but it is mainly FX headwinds that bring down our top-line estimates by low-single-digit percentages in the coming years. We reiterate our BUY rating and lower our target price per share to €173 (from €178).
Sequana announced the publication of a case report of a patient in the POSEIDON study that underwent a successful robotic hernia repair following control of their ascites with the alfapump. Looking ahead, the US commercial launch remains on track for this quarter. Should the company demonstrate initial commercial traction during the soft launch phase, this could trigger additional investor interest to fund the company into the broader launch, which is expected in 2Q26. We reiterate our € 5 TP an...
We think the May CMD cemented D'Ieteren's profile as an EPS and FCF compounder, +14% EPS CAGR 2025F-28F, +14% FCFev CAGR, a specialised listed Private Equity (PE) fund building a portfolio of growth platforms in adjacent, resilient business services companies, with a potential to rerate and D'Ieteren to invest in new high ROCE, FCF businesses with scalable franchise. We estimate a new participation could add c.15% of EBITDA by 2026/2027. We think the IPO of Belron, 70% of our SOTP, is possible b...
Aedifica: Strong results, guidance reiterated; dsm-firmenich: Symrise 1H25 results; IMCD: Stagnating gross profit leads to disappointing 2Q25 EBITA; JDE Peet's: Full of beans; Just Eat Takeaway: 1H25 results, weak update no impact on takeover; Lotus Bakeries: Peer Mondelez 1Q25 results; Melexis: 2Q25 results, gross margin under pressure; Solvay: 2Q25 in line, subdued outlook no surprise after pre-release; TKH Group: Preview: Under a magnifying glass; Universal Music Group: Spotify 2Q25 ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.